SCHEMBL14992144

SCHEMBL14992144

C=CCOC(O[SH](=O)=O)C(C)O

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3261120 0.82 CA1 (0.35) TDP1
SCHEMBL3174805 0.76 CA1 (0.32) TDP1
SCHEMBL27541066 0.75 TSHR (0.36)
SCHEMBL10387407 0.74 TDP1 (0.30) TDP1
SCHEMBL524902 0.74 TDP1 (0.30) TDP1
SCHEMBL10386047 0.73 CA1 (0.31)
SCHEMBL524903 0.73
SCHEMBL10385501 0.72
Ammonia Solution, Strong SCHEMBL1741812 0.71
SCHEMBL525966 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12163001-B2 Ion exchange membrane through UV initiation polymerization EVOQUA WATER TECHNOLOGIES LLC (US) 2024-12-10 US claimed
CN-110461888-A The purposes that aqueous polymer dispersion is bonded in high-molecular porous material interface WACKER CHEMIE AG 2019-11-15 CN claimed
US-20180346628-A1 POLYMERS FOR ORAL CARE COMPOSITIONS ISP INVESTMENTS LLC (US) 2018-12-06 US claimed
US-12163001-B2 Ion exchange membrane through UV initiation polymerization EVOQUA WATER TECHNOLOGIES LLC (US) 2024-12-10 US disclosed
US-20230130585-A1 ION EXCHANGE MEMBRANE COMPOSITION AND METHODS FOR THE CONCENTRATION OF PERFLUOROALKYL SUBSTANCES EVOQUA WATER TECHNOLOGIES LLC (US) 2023-04-27 US disclosed
US-20220062829-A1 Monovalent Selective Cation Exchange Membrane EVOQUA WATER TECH LLC (US) 2022-03-03 US disclosed
US-20220062828-A1 Monovalent Selective Cation Exchange Membrane EVOQUA WATER TECHNOLGIES LLC (US) 2022-03-03 US disclosed
WO-2021195134-A2 ION EXCHANGE MEMBRANE COMPOSITION AND METHODS FOR THE CONCENTRATION OF PERFLUOROALKYL SUBSTANCES EVOQUA WATER TECHNOLOGIES LLC (US) 2021-09-30 WO disclosed
CN-110461888-A The purposes that aqueous polymer dispersion is bonded in high-molecular porous material interface WACKER CHEMIE AG 2019-11-15 CN disclosed
US-10336933-B2 Vulcanized oil and water swellable particulate composite compositions HALLIBURTON ENERGY SERVICES, INC. (US) 2019-07-02 US disclosed
US-10039807-B2 bFGF-polymer conjugates, methods for making the same and applications thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-08-07 US disclosed
US-20160177166-A1 SEALANT COMPOSITIONS FOR USE IN SUBTERRANEAN FORMATION OPERATIONS HALLIBURTON ENERGY SERVICES, INC. (US) 2016-06-23 US disclosed
US-20150191642-A1 CEMENTING FLUID AND METHODS FOR PRODUCING THE SAME HERCULES INCORPORATED 2015-07-09 US disclosed
WO-2015040043-A1 TRIBLOCK COPOLYMERS BY RAFT POLYMERIZATION IN MINIEMULSION SYNTHOMER DEUTSCHLAND GMBH (DE) 2015-03-26 WO disclosed
EP-2851377-A1 Triblock copolymers by RAFT polymerization in miniemulsion Synthomer Deutschland GmbH (DE) 2015-03-25 EP disclosed
US-20140338916-A1 Methods and Compositions of Improving Wellbore Cleanout Treatments HALLIBURTON ENERGY SERVICES, INC. (US) 2014-11-20 US disclosed
US-20140335045-A1 bFGF-POLYMER CONJUGATES, METHODS FOR MAKING THE SAME AND APPLICATIONS THEREOF NATIONAL SCIENCE FOUNDATION 2014-11-13 US disclosed
WO-2013082196-A1 bFGF-POLYMER CONJUGATES, METHODS FOR MAKING THE SAME AND APPLICATIONS THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-06-06 WO disclosed
CN-101261219-B Method for reading test strips ROHM & HAAS 2010-09-01 CN disclosed
CN-101261219-A Method for reading test strips ROHM & HAAS (US) 2008-09-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180346628-A1 POLYMERS FOR ORAL CARE COMPOSITIONS MPO, SMARCC1, PTMA TDP1 1108/4885
US-10039807-B2 bFGF-polymer conjugates, methods for making the same and applications thereof FGF2, FGF1, FGFR1 TDP1 4035/4885
US-20140335045-A1 bFGF-POLYMER CONJUGATES, METHODS FOR MAKING THE SAME AND APPLICATIONS THEREOF FGF2, FGF1, FGFR1 TDP1 4035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.